Zoekresultaten - Takayo Matsumura

Nemolizumab Improves Patient-Reported Symptoms of Atopic Dermatitis with Pruritus: Post Hoc Analysis of a Japanese Phase III Randomized Controlled Trial door Kenji Kabashima, Takayo Matsumura, Hiroshi Komazaki, Makoto Kawashima, The Nemolizumab-JP01 Study Group

Connect to this object online.

Clinically meaningful improvements in cutaneous lesions and quality of life measures in patients with atopic dermatitis with greater pruritus reductions after treatment with 60 mg... door Kenji Kabashima, Takayo Matsumura, Yoshiteru Hayakawa, Makoto Kawashima, for the Nemolizumab-JP01 Study Group

Connect to this object online.